Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$209.01 - $232.56 $62,912 - $70,000
-301 Reduced 14.95%
1,712 $374,000
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $19,702 - $21,726
98 Added 5.12%
2,013 $404,000
Q2 2023

Aug 08, 2023

SELL
$211.93 - $241.33 $14,623 - $16,651
-69 Reduced 3.48%
1,915 $462,000
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $16,425 - $19,852
-77 Reduced 3.74%
1,984 $455,000
Q4 2022

Feb 06, 2023

BUY
$203.72 - $248.97 $23,020 - $28,133
113 Added 5.8%
2,061 $485,000
Q3 2022

Oct 27, 2022

BUY
$204.81 - $262.19 $3,276 - $4,195
16 Added 0.83%
1,948 $399,000
Q2 2022

Aug 10, 2022

BUY
$213.86 - $277.87 $59,453 - $77,247
278 Added 16.81%
1,932 $448,000
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $220,847 - $253,453
850 Added 105.72%
1,654 $441,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $218,366 - $252,624
804 New
804 $253,000
Q3 2020

Nov 09, 2020

SELL
$167.03 - $201.3 $200,436 - $241,560
-1,200 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$113.31 - $182.44 $94,613 - $152,337
-835 Reduced 41.03%
1,200 $200,000
Q1 2020

Apr 24, 2020

BUY
$104.32 - $195.28 $81,995 - $153,490
786 Added 62.93%
2,035 $258,000
Q4 2019

Feb 06, 2020

BUY
$163.48 - $173.61 $1,471 - $1,562
9 Added 0.73%
1,249 $210,000
Q2 2019

Aug 08, 2019

SELL
$144.16 - $172.9 $1,009 - $1,210
-7 Reduced 0.56%
1,240 $215,000
Q4 2018

Feb 07, 2019

BUY
$120.82 - $174.09 $2,053 - $2,959
17 Added 1.38%
1,247 $157,000
Q3 2018

Nov 01, 2018

BUY
$167.67 - $188.27 $3,688 - $4,141
22 Added 1.82%
1,230 $214,000
Q2 2018

Aug 01, 2018

SELL
$160.33 - $189.41 $4,008 - $4,735
-25 Reduced 2.03%
1,208 $217,000
Q1 2018

May 07, 2018

BUY
$161.53 - $178.11 $199,166 - $219,609
1,233 New
1,233 $199,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.